Clinical Trial Update: Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis [Phase 4]

View source ↗

Summary

This update covers a Phase 4 clinical trial evaluating antiplatelet therapy for the primary prevention of thrombosis in vascular access used for hemodialysis. C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Snippet

Sponsor: Tunis University | Conditions: Thrombosis | Phase 4 | Status: UNKNOWN